This inventor holds 2 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1993-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1994
Title: Maki Goda: Innovator in Aminopyridine Compounds
Introduction
Maki Goda is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmacology, particularly through her work on aminopyridine compounds. With a total of 2 patents to her name, her innovations are aimed at improving drug efficacy while minimizing side effects.
Latest Patents
Maki Goda's latest patents focus on aminopyridine compounds that exhibit excellent pharmacological effects. One of her inventions is an aminopyridine compound represented by a specific formula, which is designed to be effective in treating circulatory diseases. This compound is characterized by various substituents that enhance its therapeutic properties while reducing adverse effects. Another patent also involves an aminopyridine compound with a similar structure, further emphasizing her commitment to developing effective treatments for circulatory conditions.
Career Highlights
Maki Goda is currently associated with The Green Cross Corporation, where she continues to innovate in the field of medicinal chemistry. Her work has garnered attention for its potential to revolutionize treatments for various health issues, particularly those related to the circulatory system.
Collaborations
Maki collaborates with esteemed colleagues such as Sumio Matzno and Masanori Sugiura. These partnerships enhance her research and development efforts, contributing to the advancement of her innovative projects.
Conclusion
Maki Goda stands out as a dedicated inventor whose work in aminopyridine compounds holds promise for the future of pharmacology. Her contributions are paving the way for more effective and safer treatments for circulatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
